Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 13, 2017 - Issue
Submit an article Journal homepage
81
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Trend, characteristics, and pharmacotherapy of adults diagnosed with attention-deficit/hyperactivity disorder: a nationwide survey in Taiwan

Yu-Shian Cheng1 Department of Child and Adolescent Psychiatry, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine;2 Department of Psychiatry, Tsyr-Huey Mental Hospital, Kaohsiung Jen-Ai’s Home, Kaohsiung
,
Yu-Chiau Shyu3 Community Medicine Research Center, Keelung Chang Gung Memorial Hospital, Keelung;4 Institute of Molecular Biology, Academia Sinica, Nankang, Taipei
,
Sheng-Yu Lee5 Department of Psychiatry, Kaohsiung Veterans General Hospital, Kaohsiung;6 Department of Psychiatry, College of Medicine and Hospital, National Cheng Kung University, Tainan
,
Shin-Sheng Yuan7 Institute of Statistical Science, Academia Sinica
,
Chun-Ju Yang8 Institute of Biopharmaceutical Sciences, National Yang-Ming University
,
Kang-Chung Yang8 Institute of Biopharmaceutical Sciences, National Yang-Ming University;9 Genome and Systems Biology Degree Program, National Taiwan University, Taipei, Taiwan
,
Tung-Liang Lee10 Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
&
Liang-Jen Wang1 Department of Child and Adolescent Psychiatry, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of MedicineCorrespondence[email protected]
 show all
Pages 643-651 | Published online: 01 Mar 2017

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Hideyuki Imagawa, Saurabh P Nagar, William Montgomery, Tomomi Nakamura, Masayo Sato & Keith L Davis. (2018) Treatment patterns, health care resource utilization, and costs in Japanese adults with attention-deficit hyperactivity disorder treated with atomoxetine. Neuropsychiatric Disease and Treatment 14, pages 611-621.
Read now

Articles from other publishers (5)

Jacqueline M. Cohen, Chaitra Srinivas, Kari Furu, Carolyn E. Cesta, Johan Reutfors & Øystein Karlstad. (2022) Prevalence trends and individual patterns of ADHD medication use in pregnancy in Norway and Sweden, 2010–2019. European Journal of Clinical Pharmacology 79:1, pages 173-180.
Crossref
Tsutomu Nagai, Tatsuya Kurihara, Hiroaki Koya, Yukako Nakano, Satoru Sugisawa, Takehiko Sambe, Keiko Kishimoto, Mari Kogo, Haruhisa Ota, Akira Iwanami & Naoki Uchida. (2022) Identification of factors associated with the efficacy of atomoxetine in adult attention‐deficit /hyperactivity disorder . Neuropsychopharmacology Reports 42:3, pages 249-255.
Crossref
Raissa Carolina F Cândido, Cristiane A Menezes de Padua, Su Golder & Daniela R Junqueira. (2021) Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database of Systematic Reviews 2021:1.
Crossref
Mu-Hong Chen, Kai-Lin Huang, Ju-Wei Hsu & Shih-Jen Tsai. (2019) Treatment-resistant attention-deficit hyperactivity disorder: Clinical significance, concept, and management. Taiwanese Journal of Psychiatry 33:2, pages 66.
Crossref
Raissa Carolina F Cândido, Su Golder, Cristiane A Menezes de Padua, Edson Perini & Daniela R Junqueira. (2018) Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database of Systematic Reviews.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.